Cargando…
Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections
[Image: see text] The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has led to several million confirmed cases and hundreds of thousands of deaths worldwide. To support the ongoing research and development of COVID-19 therapeutics, this report provides an overview of protein targets...
Autores principales: | Zhou, Qiongqiong Angela, Kato-Weinstein, Junko, Li, Yingzhu, Deng, Yi, Granet, Roger, Garner, Linda, Liu, Cynthia, Polshakov, Dmitrii, Gessner, Chris, Watkins, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447080/ https://www.ncbi.nlm.nih.gov/pubmed/33062950 http://dx.doi.org/10.1021/acsptsci.0c00074 |
Ejemplares similares
-
Quantitative Structure–Activity Relationship
Machine Learning Models and their Applications for Identifying Viral
3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for
COVID-19 and Related Viral Infections
por: Ivanov, Julian, et al.
Publicado: (2020) -
Research and Development on Therapeutic Agents and Vaccines for COVID-19
and Related Human Coronavirus Diseases
por: Liu, Cynthia, et al.
Publicado: (2020) -
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine
Development
por: Li, Yingzhu, et al.
Publicado: (2021) -
Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis
por: Weinstein, Zohar B., et al.
Publicado: (2017) -
The BioAssay network and its implications to future therapeutic discovery
por: Zhang, Jintao, et al.
Publicado: (2011)